In the next year or so, the market for statins may get a further boost.
The National Cholesterol Education Program, the group that drafted the 2001 and 2004 guidelines on statin use, is expected to update its treatment recommendations. In doing so, the group will decide whether to suggest the broad use of statins for healthy patients with high readings of a marker for inflammation called C-reactive protein.
FOR THE RECORD:
Statin market: An article in the Aug. 9 Health section on statin users said that Dr. Sanjay Kaul is a cardiologist at USC. He is a cardiologist at the Cedars-Sinai Heart Institute. —
If the group does urge statins for these healthy individuals, at least 6.5 million new patients could sign up for long-term statin use.
Dr. Sanjay Kaul, a cardiologist at USC and a coauthor of one of the recent studies critical of the large-scale JUPITER trial, on which such a recommendation would likely be based, says such an expansion would be a mistake.